Pathogenesis and survival rate of tumor diseases such as glioblastoma and esophageal cancer have been associated with altered expression of AJAP1, thereby making it an interesting molecular diagnostic marker in cancer therapy (Han et al., 2014; Lin et al., 2012; Tanaka et al., 2015). Here, AJAP1 is linked to neoplasm.